Emerging Trends in Psoriasis Treatment Using Biologics
The Evolving Landscape of Friedreich Ataxia Care: Recent Insights and Strategies
Real-World Impact of Infliximab Precision-Guided Dosing on Management of Patients With IBD
Interchangeable Biosimilars in Inflammatory Diseases
New Therapies for Heart Failure: A Managed Care Perspective
Current and Emerging Microbiome-Targeted Therapies to Prevent Recurrent CDI: A Stakeholder Interchange Report
Perspectives On Immunotherapy in The Treatment Of Advanced NSCLC: A Stakeholder Interchange Report
Exclusive Coverage of the 2023 American Thoracic Society (ATS) International Conference
Exploring the Potential Impact of RSV Vaccines in the Adult Population
Exclusive Coverage of the American Society of Clinical Oncology 2023 Annual Meeting
Preventing Clinical Inertia in Early Treatment Management of Type 2 Diabetes
Lysosomal Storage Diseases and Other Rare Diseases: A Path to Better Management
Exclusive Coverage of the 2023 American Society of Clinical Oncology Annual Meeting
Integrated Multidisciplinary Limb Salvage Programs: Reducing Amputations Among Patients With Peripheral Artery Disease
Generalized Pustular Psoriasis: Provider and Payer Considerations for Care
Exclusive Coverage of the 72nd American College of Cardiology (ACC) Scientific Session
Exclusive Coverage of the 2023 Asembia Specialty Pharmacy Summit
Adherence to Somatropin Therapy in the United States: Highlights of a Real-world Study of Patients With Pediatric Growth Hormone Deficiency
Strategies for the Management and Treatment of Amyotrophic Lateral Sclerosis: The Value of Early Diagnosis and Clinical Intervention
Volume: 29
Issue: 7
Improving Outcomes and Quality of Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Patient-Centered Strategies in Managed Care
Issue: 6
A Review of the Current Management and Burden of Prurigo Nodularis in the United States
Exploring Emerging Therapies in Pulmonary Arterial Hypertension
Patient and Payer Considerations in Parkinson Disease Psychosis to Optimize Population Health Outcomes: A Multistakeholder Panel Discussion
Long-Term Safety and Efficacy of Esketamine in Patients With Treatment-Resistant Depression: A Review of Interim Results From the SUSTAIN-3 Trial
Striving Towards Cancer Health Equity Through Community Outreach: Highlights From a Cleveland Clinic Taussig Cancer Institute Symposium
Treatment Landscape of ALK-positive Metastatic NSCLC: A Stakeholder Interchange Report
Addressing Unmet Needs in Chronic Phase CML With Third-Generation TKI
Payer and Provider Solutions to Utilization Management Challenges in the Management of Rare Hematologic Cancers
Preventing Progression in IgA Nephropathy: A Managed Care Focus on Emerging Therapies
Issue: 3
Understanding the Role of the Complement System in Rare Disease Therapeutics
